Evidence map›Paper›PMID 42780307›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Identification and evaluation of 41 risk loci for juvenile idiopathic arthritis informs precision medicine: mechanistic implications of DNA topology and an HLA-A*02:01-ERAP2 interaction.

Hannah C Ainsworth, Ekaterina S Khvatkova, Marc Sudman, Miranda C Marion, Kaiyu Jiang, John F Bohnsack, Mary E Comeau, Patrick M Gaffney, Johannes-Peter Haas, Timothy D Howard and 18 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Hannah C AinsworthDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0003-1185-0695
Ekaterina S KhvatkovaDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0009-0000-7797-0767
Marc SudmanDivision of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0001-9061-8274
Miranda C MarionDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0003-4487-8010
Kaiyu JiangDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.
John F BohnsackDepartment of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.ORCID 0000-0003-1392-9727
Mary E ComeauDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0001-7079-8781
Patrick M GaffneyGenes and Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-1580-869X
Johannes-Peter HaasGerman Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany.ORCID 0000-0001-8117-1298
Timothy D HowardCenter for Precision Medicine, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.ORCID 0000-0003-2518-4902
Kimme HyrichCentre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0001-8242-9262
Judith A JamesArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-9574-7355
Peter A NigrovicDivision of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-2126-3702
Ellen B NordalDepartment of Pediatrics, University Hospital of North Norway, Tromsø, Norway.ORCID 0000-0001-5041-3928
Alan M RosenbergUniversity of Saskatchewan, Saskatoon, Saskatchewan, Canada.ORCID 0000-0002-0109-1595
Marite RyggDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0001-5190-151X
Samantha L SmithNIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0002-4108-8497
Vibeke VidemDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-1042-3889
Lucy R WedderburnInfection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.ORCID 0000-0002-7495-1429
Carol A WiseMcDermott Center for Human Growth and Development, Departments of Orthopedic Surgery and Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.ORCID 0000-0002-6790-2194
Rae S M YeungCell and Systems Biology Program, Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.ORCID 0000-0003-2361-725X
Susan D ThompsonDivision of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0003-4130-2796
Grant S SchulertDivision of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0001-5923-7051
Sampath PrahaladDepartments of Pediatrics and Human Genetics, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0003-3489-1756
John BowesCentre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0003-4659-031X
Sheila T Angeles-HanDivision of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.ORCID 0000-0002-9552-6464
James N JarvisDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA.ORCID 0000-0002-1878-0717
Carl D LangefeldDepartment of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID 0000-0002-4266-6949

Funding

Pediatric Rheumatology Tissue RepostoryP01AR048929 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI THOMPSON, SUSAN D · 2003 to 2015
$13.6M
Joint Biology Consortium Resource-based CenterP30AR070253 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic, Jeffrey Andrew Sparks · 2016 to 2026
$9.4M
Oklahoma Rheumatic Disease Research Cores Center (Overall Application)P30AR073750 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2018 to 2026
$8.5M
Tissue Repository CoreP30AR070549 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI Leah Claire Kottyan · 2016 to 2026
$7.7M
Predicting uveitis onset in children with juvenile idiopathic arthritisR01EY030521 · NEI · CINCINNATI CHILDRENS HOSP MED CTR · PI ANGELES-HAN, SHEILA THERESE · 2019 to 2023
$3.2M
Bridging the gap between GWAS and mechanism in JIAR01AR073201 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Peter A Nigrovic · 2019 to 2026
$3.2M
Epigenetic Mechanisms That Drive Genetic Risk in Juvenile ArthritisR01AR078785 · NIAMS · UNIVERSITY OF WASHINGTON · PI JAMES N JARVIS · 2022 to 2026
$3.1M
Defining the complex genetics of JIARC1AR058587 · NIAMS · CINCINNATI CHILDRENS HOSP MED CTR · PI THOMPSON, SUSAN D · 2009 to 2010
$1.0M
Genetics of Juvenile Idiopathic Arthritis and SubtypesR01AR057106 · NIAMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LANGEFELD, CARL D, THOMPSON, SUSAN D · 2009 to 2010
$592k
NEI NIH HHS R01 EY030521NIAMS NIH HHS P01 AR048929NIAMS NIH HHS P30 AR070253NIAMS NIH HHS P30 AR070549NIAMS NIH HHS P30 AR073750NIAMS NIH HHS R01 AR057106NIAMS NIH HHS R01 AR073201NIAMS NIH HHS R01 AR078785NIAMS NIH HHS RC1 AR058587
6 · The paper itself

Abstract

Juvenile idiopathic arthritis (JIA), the most common class of pediatric rheumatic diseases, can lead to joint damage and extra-articular features including uveitis. Early treatment can improve functional outcomes; but many patients do not respond to first-line treatments. We present a JIA Immunochip-based association analysis of rheumatoid factor-negative polyarticular JIA and oligoarticular JIA. This study spans 3,939 cases and 14,412 controls, including 1,123 cases and 1,356 controls not previously analyzed. We identify 41 (14 novel) JIA risk regions and report a JIA polygenic risk score that also associates with age of onset. Functional mechanisms presented include: a novel interaction between HLA-A*02:01 and

Identifiers

PMID42780307
PMCPMC13596673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.